In early 2019, the 6th World Symposium on Pulmonary Hypertension (WSPH) released an updated document highlighting the advances in the last five years. During the quinquennial event many experts worked together to suggest new changes in the disease diagnosis and management. Since inception of the WSPH in 1973, this is the first time when the hemodynamic definition of pulmonary hypertension (PH) has been updated. These proceedings have re-defined the different hemodynamic types of PH that occur with the left heart disease along with introduction to the genetic testing as part of pulmonary arterial hypertension (PAH) evaluation. Objective of this review is to highlight the evaluation and diagnosis of PAH based on the proceedings of the 6th WSPH. Accurate early diagnosis and subsequent management of PH is necessary, as despite of treatment advances, survival remains suboptimal.
- 6th world symposium on pulmonary hypertension (6th WSPH)
- Chronic thromboembolic pulmonary hypertension (CTEPH)
- Pulmonary arterial hypertension (PAH)
- Pulmonary hypertension (PH)
- Pulmonary veno-occlusive disease (PVOD)
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine